XPF and ERCC1 exist as a heterodimer to be stable and active in cells and catalyze DNA cleavage on the 5'-side of a lesion during nucleotide excision repair. To characterize the specific interaction between XPF and ERCC1, we expressed the human ERCC1 Binding domain of XPF (XPF-EB) and the XPF Binding domain of ERCC1 (ERCC1-FB) in Escherichia coli. Milligram quantities of a heterodimer were characterized with gel filtration chromatography, a Ni-NTA binding assay, and analytical ultracentrifugation. Crosslinking experiments at high salt concentrations revealed that XPF interacts with ERCC1 mainly through hydrophobic interactions. XPF-EB was also shown to homodimerize in the absence of ERCC1. NMR cross-saturation methods were applied to map the residues involved in formation of the XPF-EB / XPF-EB homodimer and the XPF-EB / ERCC1-FB heterodimer. Helix H3 and the C-terminal region of XPF-EB were either within or in close proximity to the homodimer interface, while the ERCC1-FB binding site of XPF-EB was distributed across helix H1, a small part of H2, H3, and the C-terminal region, most of which exhibited large changes in chemical shift upon ERCC1 binding. The XPF-EB heterodimeric interface is larger than the XPF-EB homodimeric one, which could explain why XPF has a stronger affinity for ERCC1 than for a second molecule of XPF. The XPF binding sites of ERCC1 were located in helices H1 and H3, and in the Cterminal region, similar to the involved surface of XPF. We used cross-saturation data and the crystal structure of related proteins to model the two complexes.
Introduction
DNA lesions, which interfere with DNA replication, transcription, and recombination (1), occur as a result of exogenous and endogenous damaging agents, such as UV irradiation, products of oxidative stress, and DNA-reactive chemicals. To maintain the integrity of the genome, DNA lesions are efficiently removed by DNA repair pathways, such as the nucleotide excision repair (NER) pathway, which removes various types of bulky DNA adducts. During NER, the 5' and 3' sides of a lesion are cut by two endonucleases, the XPF-ERCC1 heterodimeric complex and XPG, respectively (2) (3) (4) (5) . This dual incision is made asymmetrically around a lesion to allow its release as part of a larger DNA fragment [24- 32 nucleotides] (6) (7) (8) . The remaining gap is filled by DNA synthesis and ligation (9) (10) .
The XPF-ERCC1 complex cuts a variety of DNA substrates, including bubbles, stem-loops, splayed arms, and flaps (2, 4, 11, 12) . XPF contains the endonuclease activity, while ERCC1 likely modulates the specificity required for DNA incision (13) . XPF and ERCC1 form a stable heterodimer in mammalian cells and in vitro, and various lines of evidence suggest that both ERCC1 and XPF are unstable in the absence of each's respective partner (14) (15) (16) (17) (18) . The XPF-ERCC1 heterodimer is known to be formed through the interaction of their C-terminal domains, which each include two helix-hairpin-helix (HhH) motifs (19) (20) (21) . However, a detailed characterization of the XPF-ERCC1 heterodimeric interface has not yet been performed.
To more fully characterize the mode of interaction between ERCC1 and XPF, the human ERCC1 Binding domain of XPF (XPF-EB) and XPF Binding domain of ERCC1 (ERCC1-FB) were expressed in Esherichia coli, and milligram quantities of a soluble form of the XPF-EB/ERCC1-FB complex was generated and characterized. To decipher the nature of the XPF-ERCC1 interaction in detail, we used the soluble, recombinant complex in NMR cross-saturation experiments to map the amino acid residues that make contact between the two subunits. This enabled us to study the XPF-ERCC1 interaction at the molecular level and to propose a model for XPF-ERCC1 complex formation. Our results provide insight into the mechanisms by which XPF and ERCC1 interact specifically and tightly, and how this binding contributes to the stabilization of the subunits.
Experimental Procedures Cloning, Expression, and Purification of XPF-EB1, XPF-EB2, XPF-EB3, and ERCC1-FB
The DNA coding sequences for XPF-EB1 (amino acids 813-905) and ERCC1-FB (amino acids 224-297) were subcloned into two versions of the bacterial expression vector pET21a (Novagen) using NdeI and XhoI sites, one with a C-terminal his-tag and one without. The DNA coding sequence for XPF-EB2 (amino acids 838-901) was subcloned, with an N-terminal his-tag, into pET100/D-TOPO ® (Invitrogen). The plasmid for expression of the glutathione-S-transferase (GST)-XPF-EB3 fusion protein (amino acids 813-847) was generated from pGEX-4T-3 (Pharmacia) using the BamHI and XhoI sites. The resulting proteins are shown in Figure 1 . The nucleotide sequences of the various constructs were confirmed by DNA sequencing. The expression plasmids harboring the genes for the various versions ERCC1 and XPF were transformed into E.coli strains BL21(DE3) and BL21 for large-scale protein preparation. To produce the 15 N-labeled and 13 C/ 15 N-labeled proteins, the bacteria were grown in M9 minimal media that contained 1 g/L of 15 o C except for the steps carried out in 6M urea. The soluble his-tagged ERCC1 binding domain of XPF was purified using both a Ni-NTA agarose column (Qiagen) and a gel filtration column. After thrombin cleavage to release the N-terminal his-tag a benzamidine column (Pharmacia) was used to remove the thrombin. GST-XPF-EB3 was purified using a Glutathione Sepharose column (Pharmacia). ERCC1-FB was over-expressed in inclusion bodies, solubilized in resuspension buffer [100 mM sodium phosphate (pH 8), 200 mM NaCl, 1 mM DTT, 6 M urea], and purified using a Sepharose column (16 mm × 100 cm) charged with Sephacryl S-200 resin (200 ml; Pharmacia) under denaturing conditions. either alone or in the presence of the ERCC1 binding domain of XPF, was performed at 4 o C using two different refolding methods. One method involved stepwise dialysis to remove the denaturing agent (urea) gradually. Proteins were dialyzed sequentially over a period of 8 h against 4 M, 2 M, 1 M, 0.1 M, and 0 M urea, each in dialysis buffer [100 mM sodium phosphate buffer (pH 8), 1 mM DTT, 100 mM NaCl]. A pH of 8.0 was used because disulfide bond formation occurs more rapidly at higher pH than at neutral pH (22) ; the XPF and ERCC1 binding assays also were performed at a pH near pH 8.0 as in other reports (13, 19) . Larginine (250 mM) was added to the 1 M urea buffer to facilitate protein refolding during stepwise dialysis (23) . The second refolding method used was rapid dilution. The ERCC1-FB protein, either alone or in the presence of the ERCC1 binding domain of XPF (final protein concentration was ~80µg/ml), was refolded by making 100-fold dilutions in refolding buffer [pH 8, 100 mM sodium phosphate buffer, 1 mM DTT, 100 mM NaCl, 10 mM reduced glutathione, 1mM oxidized glutathione, and 250 mM L-arginine]. Refolding was allowed to proceed for 20 h with stirring. At the end of 20 h, the refolding solution was dialyzed against dialysis buffer. The soluble and insoluble fractions of the final protein solution were separated by centrifugation and subjected to polyacrylamide gel electrophoresis (PAGE) to identify the fractions enriched for the protein of interest.
Binding Assays using Ni-NTA Agarose
A Ni-NTA agarose column was preequilibrated with binding buffer [100 mM sodium phosphate buffer (pH 7.5), 100 mM NaCl, 5 mM imidazole, 0.05% NP-40, 0.5 mM DTT]. The detergent NP-40 was added to the buffer to prevent non-specific binding between proteins. After loading the column with protein, it was washed with 10 bed volumes of binding buffer and his-tag washing buffer [50 mM imidazole, 100 mM sodium phosphate buffer (pH7.5), 500 mM NaCl, 0.05% NP-40, 0.5 mM DTT]. The proteins were then eluted with histag elution buffer [250 mM imidazole, 100 mM sodium phosphate buffer (pH7.5), 500 mM NaCl, 0.05% NP-40, 0.5 mM DTT], and the fractions were analyzed by SDS-PAGE and Coomassie blue staining of the gel.
Binding Assays of GST-XPF-EB3(813-847) using GST Resin
The GST-XPF-EB3 (813-847) fusion protein and GST were prepared and incubated in the presence of ERCC1-FB during the refolding process described above. A Glutathione Sepharose column was preequilibrated with GST-binding buffer [100 mM sodium phosphate buffer (pH 7.5), 100 mM NaCl, 0.05% NP-40, 1 mM DTT]. After loading the column with protein, it was washed with 10 bed volumes of GST-binding buffer. Proteins were eluted with GST elution buffer (10 mM glutathione, 50mM Tris-HCl, pH 8.0), and fractions were analyzed by SDS-PAGE and Coomassie blue staining of the gel.
Gel filtration chromatography
Gel filtration chromatography [Superdex 75 prep grade (16 mm × 120 cm)] was monitored by measuring absorbance at 280 nm. The column was equilibrated with XPF-ERCC1 binding buffer [50 mM sodium phosphate buffer (pH 6), 500 mM NaCl and 1 mM DTT] before the protein preparation was applied. Molecular size standards were: bovine serum albumin (67 kDa), ovalbumin (43.5 kDa), carbonic anhydrase (29 kDa), and cytochrome C (12.4 kDa) (Sigma). Molecular sizes of the recombinant proteins of interest were calculated from a plot of the elution volume vs. the log of the molecular size.
Chemical Cross-linking
Refolded heterodimers (20 µM) were allowed to equilibrate at 4 o C in the following buffers: 50 mM sodium phosphate buffer (pH 7), 100 mM NaCl, and 1 mM DTT with various by guest on November 17, 2017 http://www.jbc.org/ Downloaded from concentrations of NaCl (75, 150, 300, 500, or 1000 mM). Glutaraldehyde is homobifunctional amine crosslinker that reacts with primary amino groups on proteins and thus has been used as a protein cross-linking reagent. Glutaradehyde was then added to the refolded heterodimer mixture to a final concentration of 0.005%. After incubation for 2 h, the reaction was quenched with a Tris (pH 6.8) solution to a final concentration of 50 mM. Products were analyzed by SDS-PAGE and visualized by Coomassie Brilliant Blue R250 staining.
Analytical Ultracentrifugation
We carried out sedimentation equilibrium ultracentrifugation experiments at 4 o C and 20 o C on a Beckman Model XLA analytical ultracentrifuge using an AN-60-Ti rotor. Most experiments were carried out using the standard 12-mm path length, six-channel, charcoal-filled epon cells with quartz windows. Continuous radial scanning at 280 nm was used for both the refolded XPF-EB1/ERCC1-FB complex (3.9, 3.8, and 4.1 mg/ml) and for XPF-EB1 (3 mg/ml). The six channels were scanned at the speeds of 18,000 and 20,000 rpm. The cells were scanned every 0.001cm, and 50 scans were averaged. The standard buffer was XPF-ERCC1 binding buffer. The default value of 1.00017 g/mL was used for the density of the solvent, and a partial specific volume of 0.73 mL/g was calculated from the weight average of the partial specific volumes of individual amino acids.
Circular Dichroism (CD)
10 µM protein samples were prepared in XPF-ERCC1 binding buffer, and CD spectra of the proteins were measured on a JASCO J-720 CD spectropolarimeter at room temperature using a cell path length of 1 mm. For urea denaturation experiments, urea was dissolved in XPF-ERCC1 binding buffer, and the samples were incubated in the urea buffer for 12 h prior to analysis by CD. (27) was used for the saturation of aliphatic protons with the irradiation frequency set to 1 ppm. A recycle delay of 3.0 s (1.8 s saturation time) was employed. The results of significantly overlapped residues were excluded when the reduction ratios of the signal intensities were calculated.
Molecular Modelling
The only structure of a dimeric HhH protein reported at the time of this work that of the Eph receptor SAM domain (28) , pdb code 1b0x. The differences in the residues comprising helix-5, and differences in the regions of contact in the XPF-EB2/ERCC1-FB complex (indicated by cross saturation experiments) relative to what is seen in the crystal structure indicated that modeling the interface in the XPF-EB2/ERCC1-FB complex based on the SAM domain structure would be problematic. To generate a model for the XPF-EB2/ERCC1-FB complex a structure of each protein was first generated by carrying out homology modeling based on PDB using MODELLER 6v2 (29) . Models for XPF-EB2 and ERCC1-FB were built onto SAM domain (pdb code 1b0x) and C-terminal domain of UvrC (pdb code 1kft) as a template with the highest identity and similarity respectively. Restrained energy minimization was used for portions of the model which required manual refinement and the model consistency was assessed with PROCHECK (30). The resulting structures were then used to generate a model for the heterodimer complex using the program AUTODOCK 3.05 (31) . The molecule was allowed to move in a cubic box large enough (68Å edge). The electrostatic potential grid of this cubic box was calculated using a grid spacing of 0.75Å.
Step sizes of 2Å for translation and 50º for rotation were chosen, and the maximum number of energy evaluations was set to 250,000. For the genetic algorithm, a population size of 50 was used, and the maximum number of generations was set to 27,000. The best complex was chosen according to the lowest energy. After submission of this manuscript a new structure appeared for an archaeal XPF homodimer (32) including nuclease and (HhH) 2 domains. The sequences of human XPF and ERCC1 were threaded to the individual monomers of this model, using Swiss-PDBViewer 4.7, for comparison.
Results and Discussion

Aggregated ERCC1-FB is Refolded Only in the Presence of its Interaction Partner XPF-EB
XPF-EB1 (813-905) carrying a Cterminal his-tag was expressed as a soluble protein in E. coli strain BL21(DE3). In contrast, non-his-tagged ERCC1-FB (224-297) was expressed exclusively in inclusion bodies in the same E. coli strain (Fig. 1) . Although a variety of expression vectors, E. coli strains, and culturing temperatures were tested, we were unable to produce soluble ERCC1-FB. To try to obtain a soluble form of the protein, we disrupted the aggregated ERCC1-FB in resuspending buffer that contained the denaturing reagent urea and then refolded the protein in vitro at 4 o C by stepwise dialysis or rapid dilution of the urea concentration. Although we modulated various factors, including pH, composition of the refolding medium, and redox conditions, the bulk of the ERCC1-FB remained aggregated during the refolding process.
We next tried to refold ERCC1-FB in the presence of XPF-EB1 using stepwise dialysis or rapid dilution. The two recombinant proteins were combined in the 6M urea initial buffer described above, and the mixture was subjected to stepwise dialysis to eliminate the urea. In addition, ERCC1-FB that had been solubilized in the 6M urea buffer was subjected to rapid dilution with refolding buffer that contained XPF-EB1. After stepwise dialysis or rapid dilution, most of the ERCC1-FB protein, along with the XPF-EB1 protein, was recovered in the soluble fraction, which could be concentrated to yield an ERCC1-FB/XPF-EB1 preparation that was greater than 1 mM. The 1 H-NMR spectra of the proteins refolded by the two methods were identical (data not shown), indicating that both methods yielded comparably folded proteins in an efficient manner.
To examine the structural stability of XPF-EB1, urea-induced unfolding of XPF-EB1 was monitored by far UV CD using ellipticity changes at 222 nm, Fig. 2A . Loss of the minimum at 222 nm indicates the disruption of α-helical structure, which is a major structural component of XPF-EB1. The unfolding of XPF-EB1 did not occur until the urea concentration reached 6M (Fig. 2A) ; this finding suggests that, during the refolding of ERCC1-FB in the presence of XPF-EB1 described above, most of the XPF-EB1 had a secondary structure similar to the native state. This result could explain the high yields from the refolding process used for the XPF-EB1/ERCC1-FB complex. That is, during the refolding of this protein complex, XPF-EB1, which was mostly structurally intact, prevented the aggregation of the exposed hydrophobic regions of ERCC1-FB and/or acted as a template to induce the proper folding of ERCC1-FB.
Refolded ERCC1-FB and XPF-EB1 Bind Tightly to Each Other in a One-to-one Ratio by Hydrophobic Interactions
In order to determine whether refolded XPF-EB1 and ERCC1-FB are functionally active (ERCC1-FB binds tightly and specifically to XPF-EB1), binding assays using Ni-NTA agarose were performed. A mixture containing the refolded complex (XPF-EB1 with a C-terminal his-tag and ERCC1-FB) was loaded on a Ni-NTA affinity column, and the resin was extensively washed with Ni-NTA binding and his-tag washing buffer to eliminate nonspecific binding. ERCC1-FB remained adhered to the column along with XPF-EB1, revealing that ERCC1-FB was bound tightly to XPF-EB1 (Fig. 2B) showing that the refolded proteins retain their ability to bind to each other, which is the key function of these domains. Other reports have shown that active XPF-ERCC1 complexes can be prepared using methods that involve co-expression and copurification, reflecting strong interactions between XPF-EB1 and ERCC1-FB (2, 12) .
On the basis of their amino acid sequences, XPF-EB1 and ERCC1-FB have predicted monomeric molecular weights of 11 and 8.2 kDa, respectively. In order to determine the stoichiometry of the refolded XPF-EB1/ERCC1-FB complex, gel filtration chromatography and equilibrium sedimentation were performed. The hydrodynamic molecular size of non-refolded XPF-EB1 was analyzed on a Superdex 75 gel filtration column. XPF-EB1 eluted as a single peak at 64.51 min, which corresponds to a molecular weight of 38 kDa, consistent with either a trimer of globular shape or dimer with an extended shape. The refolded XPF-EB1/ERCC1-FB complex eluted as a single peak at 71.19 min, a significantly longer elution time than that of XPF-EB1 alone, and corresponding to a molecular weight of 25.2 kDa (Table 1) . We also tested refolded XPF-EB1 alone, which eluted at the same position as native XPF-EB1 on a gel filtration column. These results indicate that the refolded XPF-EB1/ERCC1-FB complex is a one-to-one heterodimeric complex with a slightly extended conformation, and that XPF-EB1 binds preferentially to ERCC1-FB despite competition from the self-association reaction of XPF-EB1.
To confirm the gel filtration data, we performed analytical ultracentrifugation equilibrium sedimentation experiments. The concentration of protein versus radius data were fitted with various models and were best described by a single component model. The equilibrium sedimentation data yielded a molecular weight of 17,863±600 g·mol -1 for the refolded XPF-EB1/ERCC1-FB complex for the different rotor speeds, protein concentrations, and temperatures used ( Table 2) . This supports the conclusion that the XPF-EB1/ERCC1-FB complex has a stoichiometry of one ERCC1-FB molecule bound per monomer of XPF-EB1, and that the 25-kDa size observed with gel filtration chromatography results from an elongated shape for the complex. In addition, equilibrium sedimentation results showed that XPF-EB1 alone had a molecular weight of 21,060±300 g·mol -1 at 4 o C (Table 2) , which implies that XPF-EB1 exists as a homodimer.
To determine whether electrostatic interactions are important in the interaction of XPF-EB1 and ERCC1-FB, we assessed the cross-linking of the complex by glutaraldehyde in the presence of varying sodium chloride concentrations, analyzing products by SDS-PAGE. Variation in the sodium chloride concentration from 0.075 M to 1 M did not alter the cross-linked patterns, although the intensity of the protein bands (lane 5, 6) in the SDS gel was slightly decreased at high salt concentrations, Fig. 2C , suggesting that formation of this complex is driven mainly by hydrophobic interactions. We also optimized the solvent conditions for NMR studies of this complex and observed that the complex showed reduced tendency to aggregate at higher salt concentrations (data not shown). Finally, the same cross-linking experiment with XPF-EB1 alone indicates that the XPF-EB1 homodimer is also driven by hydrophobic interactions (Fig. 2C) . Other studies have highlighted the importance of hydrophobic interactions in distinct structure-specific endonuclease complexes that participate in NER, such as UvrB and UvrC E.coli (33) , and in the binding of Rad1 with Rad10 in S. cerevisiae (34) .
Characteristics and Secondary Structure of the XPF-EB2 Homodimer and the XPF-EB2/ERCC1-FB complex
We next used NMR to probe the interface of the XPF-ERCC1 complex. Assigned chemical shifts for the individual subunits and the complex are required for solution structure determinations and for probing the interface in the complex. We first collected a 2-D 15 N-1 H HSQC (heteronuclear single quantum coherence) spectrum of soluble 15 N-XPF-EB1. Unfortunately, because of flexible N-and Cterminal regions of XPF-EB1, we observed many overlapped peaks with strong intensities in the central region of the HSQC spectrum and severe overlap of resonances in the 3-D NMR spectrum which hampered assignment of the 13 C, 15 N, and 1 H resonances (data not shown). To eliminate these problems, we subcloned the DNA coding sequences for XPF-EB2 (838-901) (Fig. 1) with the N-terminal his-tag in such a way as to remove the terminal regions that were thought to be flexible on the basis of secondary structure predictions. The resulting construct was expressed as a soluble protein (XPF-EB2) in E. coli BL21(DE3). In order to confirm that refolded XPF-EB2 and ERCC1-FB display the same characteristics as XPF-EB1 and ERCC1-FB, XPF-EB2 was subjected to the same binding assays and gel filtration chromatography as XPF-EB1. The Ni-NTA binding assay data showed that ERCC1-FB (which did not have a his-tag) was retained on the column (Fig. 3A) , which indicates binding to ERCC1-FB. In gel filtration chromatography XPF-EB2 eluted as a single peak at 78.8 min, which corresponds to a molecular size of 16.4 kDa, consistent with a dimer ( 15 N-XPF-EB2 had a structure very similar to the folded part of XPF-EB1 (data not shown). Both soluble XPF-EB2 alone and the refolded XPF-EB2/ERCC1-FB complex showed well-dispersed 15 N and 1 H resonances in the HSQC spectrum, with relatively uniform linewidths, indicating that the XPF-EB2 homodimer and the XPF-EB2/ERCC1-FB heterodimeric complex are well folded (Fig. 3, B, C and D) . The number of peaks in the 15 N-1 H HSQC spectrum of 15 N-XPF-EB2, Fig. 3B , is very close to the number of amino acids in the XPF-EB2 monomer, indicating a symmetric homodimer.
We next performed 3-D triple resonance experiments with 13 C, 15 N-XPF-EB2 alone, for the 13 C, 15 N-XPF-EB2/ 14 N-ERCC1-FB complex, and for the 14 N-XPF-EB2/ 13 C, 15 N-ERCC1-FB complex, in order to probe the secondary structure of XPF-EB2 and ERCC1-FB. From these 3-D NMR analyses, we assigned the main-chain resonances of the XPF-EB2 homodimer and the XPF-EB2/ERCC1-FB complex. On the basis of chemical shift index analysis using (H α , C α, C β CO) (35), we determined the secondary structure in both the XPF-EB2 homodimer and XPF-EB2/ERCC1-FB complex (Fig. 4A, B, D) . In agreement with previous studies that predicted the existence of (HhH) 2 motifs in both XPF-EB2 and ERCC1-FB (21), our data show that the XPF-EB2 homodimer consists of five α-helices (H1, 838-842; H2, 849-857; H3, 862-866; H4, 870-876; and H5, 879-891) per monomer. XPF-EB2 in the heterodimer complex has a similar secondary structure, with the same five α-helices (H1, 838-842; H2, 849-857; H3, 862-866; H4, 870-876; and H5, 880-892). These results show that refolding of the ERCC1 binding domain of XPF is not required for conversion of the homodimeric complex to the heterodimeric complex. ERCC1-FB, again in the context of the heterodimeric complex, was also shown to have five α-helices in (HhH) 2 motifs (H1, 233-240; H2, 247-257; H3, 260-265; H4, 268-272; and H5, 280-288) and an additional α-helix in the N-terminal region (226-229).
Interface of the XPF-XPF Homodimer
We mapped the interface in the XPF-EB2 homodimer using cross-saturation methods (26) , which can identify protein-protein interfaces reliably on the basis of saturation transfer from a non-labeled to a labeled protein (36) . Cross-saturation decreases the intensity of 1 H-15 N cross-peaks that result from amino acid residues that reside at the molecular interface. In our experiments, the resonance corresponding to Ala863 exhibited the greatest decrease in intensity (~55%), Fig. 4A , implying that it is a residue at the interface with the nonlabeled XPF-EB2 molecule. Other residues that appeared to be at the interface include XPF-EB2 residues: Ile862, Glu864, Leu865, Ala866, Ala867, Ile890, His891, Thr892, Phe894 as they were most affected by cross-saturation from the non-labeled XPF-EB2 molecule. These amino acid residues reside in helix H3 and in the C-terminal region of XPF-EB2. About 60% of the binding interface residues identified are found to be hydrophobic in nature, and thus could contribute to the hydrophobic interactions stabilizing the homodimer as suggested by the crosslinking data.
Formation of the XPF-ERCC1 heterodimer is required to create a stable and active endonuclease. A small amount of XPF protein persists in ERCC1-deficient cells even in the absence of complex formation with ERCC1 (4, 21). The self-associated form of XPF has not yet been observed in vivo, however previous observations and the findings described here show that XPF has a strong tendency to self-associate in the absence of its partner (21). As described above the ERCC1 binding region of XPF associates in vitro to form a stable homodimer, a process that seems likely to occur under physiological conditions as well. The endonuclease activity of the XPF-ERCC1 complex is associated with XPF, while ERCC1 likely modulates the specificity required for DNA incision during the repair process (13) . It has been suggested that it might be advantageous for XPF that is not bound to ERCC1 to exist in a selfassociated state that does not have nuclease activity, as this would reduce the amount of nonspecific DNA cleavage. Consistent with this hypothesis, no endonuclease activity has been observed for self-associated XPF (21). Our results suggest that the ERCC1 binding region of XPF serves as the self-association domain in the absence of ERCC1.
Interface of the XPF/ERCC1 Complex
XPF binds specifically and tightly to ERCC1 both in vivo and in vitro (4, 14, 15, 19) .
In order to understand the characteristics of the XPF-ERCC1 heterodimeric interface, mapping of the contact residues involved in the interaction between XPF and ERCC1 is necessary. To identify amino acid residues involved in formation of the XPF-ERCC1 interface we again performed cross-saturation experiments. Fig. 4B shows the 21 residues of XPF: Gln838, Asp839, Phe840, Leu842, Lys843, Met844, Met856, His857, Asn861, Ile862, Ala863, Glu864, Leu865, Ala866, Ala867, Phe889, Ile890, His891, Thr892, Phe894, Ala895, for which the intensities of the 1 H-15 N cross-peaks were significantly affected by the cross-saturation. These residues are distributed along helix H1, a small part of helix H2, helix H3, and the C-terminal region. The resonance of Ala863 in H3 exhibited the greatest decrease in intensity (~63%), as was the case for the XPF homodimer. Other residues that showed decreases in intensity nearly as large were Phe840 of H1 and Ile862 of H3. Met856 and His857 in H2 had smaller decreases in intensity than did the contact residues, but still showed a clear decrease in intensity relative to non-contact residues. About ~60% of the binding surface residues at the interface are hydrophobic in the heterodimer, consistent with the cross-linking data. The aggregation of free ERCC1 may be caused by an exposed hydrophobic surface that cannot efficiently homodimerize, and is shielded by interaction with XPF in the heterodimer. Helix H3 and the C-terminal region of XPF contain residues that participate in both homodimer and heterodimer formation. We believe that the preference XPF displays for ERCC1 is specified by helix H1 in XPF. Helix H1 has more polar contact residues (e.g. Asp839 and Lys843) than do the other helices in the heterodimer interface. The interface mapping results indicate that the surface of the XPF interface in the heterodimer is larger than that in the homodimer, which could be responsible for driving heterodimer formation.
The combined 1 H and 15 N chemical shift changes between the ERCC1 bound and homodimeric states of XPF are plotted in Fig.  4C . The residues with large chemical shift changes are localized in H1, H2, H3, and the C-terminal region and are generally consistent with the XPF contacts to ERCC1 based on cross saturation, excepting Asn851, Cys852 and Arg853 in helix H2. These residues in H2 might reflect a conformational change occurring in or around H1 to form the heterodimer interface. The ERCC1 binding domain of XPF (814-905) was first identified by de Laat et al. (19) , and subsequently McCutchen-Maloney et al. localized it to amino acids 656 to 843 (13) . Together these two studies implicate the region between amino acids 814 and 843 (13) . To further define the contribution of XPF(813-843) to heterodimer formation, we made a recombinant GST-XPF-EB3 (813-847) fusion protein, which contains the residues of the first helix that is part of the ERCC1 binding domain of XPF. GST-XPF-EB3 was refolded by the same method used for ERCC1-FB and showed clear but weak binding to ERCC1-FB (Fig. 5) . This result shows that XPF amino acids 813 through 847 are sufficient for binding, albeit weakly, to ERCC1-FB, and that the H1 region of XPF-EB is important for recognition of the binding interface of ERCC1. However the rest of the ERCC1 binding domain of XPF is required for strong binding of XPF to ERCC1-FB.
To identify the binding residues of ERCC1 within the heterodimeric complex, we performed further cross-saturation experiments.
Residues that appear to be in the interface region include: Arg234, Cys238, Thr240, Thr241, Leu260, Glu261, Ile264, Ala265, Val288, Leu289, His290, Glu291, and Leu294, located in H1, H3, and the C-terminal region of ERCC1 (Fig.  4D) . The resonance corresponding to Glu261 in H3 exhibited the greatest decrease in intensity (~47%). Cys238 of H1 also exhibited decrease in its intensity that was nearly as great as that of Glu261. It is interesting that the parts of the sequence forming the interface in ERCC1 are similar to those in XPF. Considering the secondary structure similarity and ~64% primary sequence homology between the interaction domains of XPF and ERCC1, the heterodimer might be nearly symmetrical in structure as is the XPF homodimer. De Laat et al. (19) had suggested that residues 293-297 in ERCC1 are important for XPF binding even though they are not part of the (HhH) 2 motif. Consistent with this suggestion, we also observed that Leu294 of ERCC1 as a contact residue. We could not specifically probe Phe293 because of peak overlap, though a descrease in the peak containing Phe 293 was seen and hence it could be a contact residue. Additional α-helices in the N-terminus that are not part of the (HhH) 2 motifs of ERCC1-FB do not appear to be necessary for interface formation.
The HhH motif has been predicted to exist in several DNA repair proteins and has been shown to mediate mainly non-sequencespecific interactions with DNA (37-39). For instance, the (HhH) 2 motifs of the C-terminal domain of the E. coli XPF homolog UvrC are required for DNA binding to a 5' incision point in the prokaryotic NER process (40) . Although the ERCC1 binding domain of XPF and the XPF binding domain of ERCC1 have (HhH) 2 motifs, our data show that these structures are used for protein-protein interactions instead of binding to the DNA. The homodimeric structure formed by the sterile alpha motif (SAM) domain in the EphA4 receptor tyrosine kinase was determined by xray crystallography (28) . The SAM domain can homo-and hetero-oligomerize with other SAM domains and is composed of (HhH) 2 motifs that mediate the various protein-protein interactions (28) . This domain is similar to the (HhH) 2 motifs of both XPF and ERCC1 and shares 55% sequence homology with these domains. The interface of the SAM homodimer consists of the N-terminal strand, C-terminal helix H5, helix H1, and H3. The interface in the XPF-ERCC1 complex appears to be related to that of the Eph receptor SAM domain homodimer, however with significant differences in details. The structure of the SAM dimer is shown in Figure 6A , looking down the two fold axis. The dimer interface is comprised of an N-terminal segment that is extended, and the C-terminal portion of helix-5 plus a two residues beyond the helix. Comparing the sequences and secondary structure (for ERCC1 and XPF based on the NMR data), Figure 1 , it is immediately apparent that there are both differences in structure and contacts for the equivalent regions of ERCC1 and XPF. First, in the SAM dimer the contacts to the N-terminal region involve residues before the first helix, whereas contacts in XPF-ERCC1 involve residues in the first helix. Second in the SAM dimer there is just one contact in the region of helix-3, whereas this is a major contact region for XPF-ERCC1. Third, in the SAM dimer the intermolecular contacts in the C-terminal region involve residues at the end of its elongated helix-5. In the XPF-ERCC1 complex contacts are shifted toward the N-terminus by at least 6 residues, and involve residues that are not helical. Figure 6 shows the residues involved in contacts in the XPF-ERCC1 complex (Fig. 6A ) mapped onto the SAM dimer structure. It is clear that the contact residues are far from the interface. To get a better model for the XPF-ERCC1 dimer the ERCC1 and XPF structures were each built by homology modeling onto previously determined HhH structures, and then brought together using the program AUTODOCK, with the result shown in Figure 6B . Contact residues defined by cross saturation are shown as colored highlights. This model brings the appropriate regions into proximity. There are a few unmodeled residues, particularly at the Cterminus, that are not helical and may wrap up onto the dimer partner to make additional contacts. Since the individual domain models are only homology models, and the juxtaposition is by docking with very loose restraints one must view this as a rough model. While this manuscript was in review, the structure of an archaeal XPF homolog dimer, containing nuclease and (HhH) 2 domains was reported (32) . Threading the human sequences onto the structure of the (HhH) 2 domain (pdb 2bhn) yielded the results shown in Figure 6C , qualitatively similar to the AUTODOCK model, 6B, the biggest difference being a rotation of the proteins relative to one another. The NMR data reported here indicate small differences in secondary structure in the human XPF-ERCC1 proteins relative to the archaeal, but the similarity is sufficient to support a model for the human XPF homodimer and the XPF-ERCC1 complex that has similar general features. Determination of the full 3-D structures of these complexes is currently under way in our laboratories.
Biological Implications of XPF-ERCC1
Interface XP (Xeroderma pigmentosum group)-F patients have skin that is highly sensitive to ultraviolet irradiation from the sun. These patients carry a truncated verision of the XPF protein caused by a frameshift mutation that inserts a premature stop codon in front of the ERCC1 binding domain, or a point mutation, R788W, which is known to affect heterodimeric complex formation (41) . Reduced concentrations of both the XPF and the ERCC1 proteins are observed in these patients, even though the genes encoding XPF and ERCC1 are localized to different chromosomes (16) . It has been shown that a normal amount of ERCC1 mRNA is transcribed in XPF-defective cells (42) , and no evidence for a lowered level of translation of ERCC1 in XPF deficient cells exists. The ERCC1 protein concentration can be increased in XPF-defective cells by transfection with an expression vector encoding wild-type XPF (43) . These data imply that the stability and function of ERCC1 in the cell are dependent on heterodimer formation with XPF. However, until now, the molecular characteristics of the XPF-ERCC1 interaction had not yet been elucidated. Our results help to clarify the basis for the specific and tight binding that characterize the XPF-ERCC1 interaction. In addition, we suggested that homodimerization of the ERCC1 binding domain of XPF is likely to occur under physiological conditions. Consequently, the ERCC1 binding region of XPF may possess at least two functions, ERCC1 binding and self association, and these functions likely are important for the regulation of XPF endonuclease activity and, therefore, the DNA repair process. receptor tyrosine kinase, and XPF. Bold residues indicate helical residues from published structures of UvrC (pdb 1kft) (grey = poorly defined helix) and SAM (pdb 1b0x), helical residues in ERCC1, XPF blue = helix (based on NMR chemical shift index). Underlines in the SAM sequence indicate contact residues (< 4Å) between monomers in the dimer structure. ◊ indicates residues in the XPF-ERCC1 heterocomplex for which cross saturation was observed; o indicates the same for the XPF homerdimer complex. . The structure of the Eph receptor SAM domain dimer (pdb 1b0x) is shown in A with contact residues from ERCC1 and XPF indicated by orange and red colors. In B the AUTODOCK model of the homology modeled ERCC1 and XPF domains in complex is shown (ERCC1 in green, XPF in blue) with contact residues to the partner again mapped in orange and red. In C the model based on the archaeal XPF dimer (pdb 2bhn) is shown with the same coloring including contact residues. 
